Search

everythinglearnresearchcommunity

for

Search:↓

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Radiation-induced alopecia after angioembolization usually heals on its own and can look like other hair loss types, but patient history helps prevent misdiagnosis.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Ayurvedic treatment may improve quality of life for cancer patients undergoing chemo and radiotherapy.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Imuvert can prevent some chemotherapy-induced hair loss.

Activated protein C helps protect mice from radiation damage.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Provenge extends prostate cancer survival by about 4 months.

Pulsed electric field treatment may help shrink untreated liver tumors.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

A 30 Gy radiation dose effectively causes severe radiodermatitis in rabbits.

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

Antioxidant vitamins, especially vitamin E, help reduce radiation-induced intestinal damage.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Reporter characteristics affect detection of hair loss from cancer therapy.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Rind-based techniques can lower scalp radiation dose and reduce hair loss in brain cancer treatment.

Dutasteride injections can help treat hair loss in men and women.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.